Market Overview

Morning Market Movers

Related NBIX
Benzinga's Volume Movers
Morning Market Gainers
Related EPZM
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
Epizyme Updated Tazemetostat Phase 1 Data Show Clinical Activity in a Broader Range of Adults With INI1-Negative and SMARCA4-Negative Solid Tumors

Neurocrine Biosciences (NASDAQ: NBIX) jumped 60.40% to $15.66 after the company reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study.

Epizyme (NASDAQ: EPZM) moved up 55.32% to $31.84 after the company reported two major milestone achievements. It announced the achievement of a proof of concept milestone in the EPZ-5676 DOT1L inhibitor clinical program.

Verso Paper (NYSE: VRS) rose 31.70% to $4.23 after the company announced its plans to acquire NewPage for $1.4 billion.

Stereotaxis (NASDAQ: STXS) shares jumped 19.26% to $4.77 after the company Stereotaxis completed the clinical trial of Vdrive with V-Loop.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (NBIX + EPZM)

View Comments and Join the Discussion!

Get Benzinga's Newsletters